Avoro Capital Advisors LLC Xenon Pharmaceuticals Inc. Call Options Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XENE
# of Institutions
228Shares Held
69MCall Options Held
307KPut Options Held
68.9K-
Driehaus Capital Management LLC Chicago, IL4.32MShares$158 Million2.04% of portfolio
-
Wellington Management Group LLP Boston, MA3.92MShares$143 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$98 Million0.02% of portfolio
-
Polar Capital Holdings PLC London, X02.61MShares$95.5 Million0.7% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.48MShares$90.8 Million4.01% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.28B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...